NCT07628608
Safety and User Experience of BP-CBB
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial completed
- Enrollment target: estimated 60 to confirmed 58
- Primary and study completion dates changed from estimate of Dec 1, 2026 to Nov 11, 2026
- Notable Eligibility criteria expanded, about 34 words
- Enrollment closed, study ongoing
- Site details revised
- Notable Recruitment opened
- Start date changed from estimate of Jul 1, 2026 to Jun 16, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
To evaluate the safety and tolerability of once daily intake of the novel food ingredient BP-CBB in healthy adults
Timeframe: 8 weeks
Arms and interventions
Test armExperimental
Receives Test product containing BP-CBB
Placebo armPlacebo comparator
Receives Placebo product without BP-CBB
Dietary supplements: BP-CBB, Placebo
Sites
1 site in 1 country
- Atlantia Clinical TrialsCork, Ireland